Search

everythinglearnresearchcommunity

for

Search:↓

Photodynamic therapy shows promise for oral lichen planus but needs more research for consistent results.

A patient with a rare scalp condition showed improvement with isotretinoin and other medications.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

Minoxidil can cause a rare but serious condition that leads to fluid buildup around the heart and drug-induced lupus.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

Vitamin A toxicity can cause severe health issues and may require a liver transplant if other treatments fail.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

The donkey had a severe disease affecting multiple organs and was euthanized.

Minoxidil can cause life-threatening heart complications, so careful monitoring is essential.

A 36-year-old woman with low potassium levels was found to have Cushing disease, and after treatment, her potassium levels normalized.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Hair removal with intense pulsed light can cause rare skin lesions that are hard to fully treat.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

The guidelines standardize mesotherapy practices for safety and effectiveness in pain, rehabilitation, and skin treatments.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Combining PRP, light therapy, and microneedling can significantly regrow hair in severe alopecia cases.

Cyclosporine effectively treated a woman's stubborn skin condition.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Minoxidil effectively controls blood pressure in severe cases, but may cause fluid retention and edema.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.